{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-23-000054","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.801616+00:00","generated_at":"2026-06-13T20:28:06.405479+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Integra LifeSciences appoints Lea Daniels Knight as EVP and CFO effective June 28","bullets":["Knight brings over 30 years of experience, most recently as EVP Business Finance at Booz Allen Hamilton, and 18 years at Johnson & Johnson.","Compensation includes $600K base salary, 90% target bonus, $1M RSU grant, $350K cash sign-on, and $1.65M 2024 LTI target.","Jeff Mosebrook ceases as principal financial officer but remains SVP Finance and principal accounting officer.","Appointment effective June 28, 2023; Knight succeeds interim CFO role held since February 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-23-000054","json":"https://secwatch.observer/filing/0000917520-23-000054.json","markdown":"https://secwatch.observer/filing/0000917520-23-000054.md","text":"https://secwatch.observer/filing/0000917520-23-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/0000917520-23-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/iart-20230621.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:28:06.405479+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c37f4bf226","claim":"Lea Daniels Knight was appointed as Executive Vice President and Chief Financial Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"On June 21, 2023, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Lea Daniels Knight to serve as its Executive Vice President and Chief Financial Officer effective June 28, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/0000917520-23-000054-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}